AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026Net selling: insiders sold $1K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$1K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 7- Open
- $2.65
- 52-wk high
- $5.38
- High
- $2.65
- 52-wk low
- $2.23
- Low
- $2.41
- Prev close
- $2.63
- Mkt cap
- $106.2M
- Volume
- 327.5K
- P/B
- 0.7x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -46.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about OKUR filings
Are insiders buying or selling OnKure Therapeutics, Inc. (OKUR) stock?
Net selling: insiders sold $1K and bought $0 of OKUR stock on the open market in the 90 days to Oct 7, 2026, according to SEC Form 4 filings. The largest was Leverone, Jason A. (Chief Financial Officer), who sold $898. The latest filing was on Sep 23, 2026.
Which members of Congress have traded OKUR recently?
None. No member of Congress disclosed a OKUR trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this OKUR smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in OKUR right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
Reports Nov 5, 2026, in 29 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $106M
Valuation
- P/B0.69
Quality
- Operating margin0.0%
- ROE-46.9%
- ROA-29.3%
Growth
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace